ArticleTranslational and clinical pharmacology2022

Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19.

Yong-Soon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.